Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema

PURPOSE: To examine the utilization of bevacizumab and ranibizumab and disease monitoring in patients with branch or central retinal vein occlusion (BRVO/CRVO) or diabetic macular edema (DME) in clinical practice. PATIENTS AND METHODS: This retrospective claims analysis included newly diagnosed pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiss, Szilárd, Liu, Ying, Brown, Joseph, Holekamp, Nancy M, Almony, Arghavan, Campbell, Joanna, Kowalski, Jonathan W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155807/
https://www.ncbi.nlm.nih.gov/pubmed/25210429
http://dx.doi.org/10.2147/OPTH.S60893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155807/
https://www.ncbi.nlm.nih.gov/pubmed/25210429
http://dx.doi.org/10.2147/OPTH.S60893

Ejemplares similares